296 research outputs found
Українська шляхта між польським та українським етносами
Appearance and existence of the Ukrainian gentry relates to the traditions of Polish political culture, so during the whole period of its life it was between the Ukrainian and the Polish ethnic groups. Polanisation of the Ukrainian gentry begins at the date when some of the Ukrainian territories become a part of Poland and strengthens after Cossack revolution in the middle and at the end of the 16th century. Especially this process becomes effective at the beginning of the 18th century when a great part of gentry from other Polish lands migrates to Pravoberezhia (right-banked Ukraine). Nevertheless, having captured upper class and partially middle class of the Ukrainian gentry, polanisation mainly influenced consciousness and less religion of the lower class of the Ukrainian gentry. As for ethnoculture and language local gentry was mostly Ukrainian and it assimilated numerous Polish gentlemen-immigrants
Fermi Surface Properties of Low Concentration CeLaB: dHvA
The de Haas-van Alphen effect is used to study angular dependent extremal
areas of the Fermi Surfaces (FS) and effective masses of CeLaB alloys for between 0 and 0.05. The FS of these alloys was previously
observed to be spin polarized at low Ce concentration ( = 0.05). This work
gives the details of the initial development of the topology and spin
polarization of the FS from that of unpolarized metallic LaB to that of
spin polarized heavy Fermion CeB .Comment: 7 pages, 9 figures, submitted to PR
BIM : a methodology to transform business processes into software systems
This manuscript proposes a guiding methodology to obtain a software system that supports the execution of the business processes existing within an organization. The methodology promotes the usage of business process reference models and intends to reduce the implementation time of the software systems. The methodology assumes four distinct phases and several abstraction levels and is applicable both when developing systems from scratch or in re-engineering contexts. The methodology embodies a special phase to handle the diversity of the business processes of an organization. By tailoring process reference models and by considering the characteristics of a specific organization, a proper set of business processes is derived for that organization. Then, we can obtain a suitable information system and implement its automatable parts in a software solution that can run on top of open source software frameworks. We also present four new supporting concepts to the methodology, and a summarized execution of it
Randomized controlled trial of vacuum therapy for intermittent claudication
OBJECTIVE: The "gold standard" treatment of intermittent claudication (IC) is supervised exercise therapy (SET). Intermittent vacuum therapy (IVT) has recently been promoted as an additional treatment of IC. During IVT, negative pressure and atmospheric pressure are alternatingly applied to the lower extremities, possibly resulting in improved circulation. The aim of this study was to determine a potential additional effect of IVT in IC patients undergoing a standardized SET program. METHODS: IC patients were recruited from three Dutch general hospitals between December 2015 and July 2017. They received a standardized SET program but were also randomly assigned to an intervention group receiving an IVT treatment (-50 mBar negative pressure) or a control group receiving a sham treatment (-5 mBar negative pressure). IVT was provided in a dedicated clinic during 12 sessions of 30 minutes during a 6-week period. The primary outcome measure was a change in maximal treadmill walking distance. Secondary outcome measures were a change in functional treadmill walking distance, 6-minute walk test, ambulatory ability, and quality of life. RESULTS: A total of 78 patients were randomized, of whom 70 were available for intention-to-treat analysis (control, n = 34; intervention, n = 36). At 6 and 12 weeks, increases in walking distance were of equal magnitude. Median (interquartile range) change in maximal treadmill walking distance during 12 weeks was +335 (205-756) meters in control patients and +250 (77-466) meters in intervention patients (P = .109), whereas functional treadmill walking distance increased +230 (135-480) meters and +188 (83-389) meters (P = .233), respectively. Mean ± standard deviation change in the 6-minute walk test was +36 ± 48 meters and +55 ± 63 meters (P = .823), respectively. Ambulatory ability and quality of life improved equally in both groups. CONCLUSIONS: IVT does not confer any additional beneficial effects in IC patients undergoing a standardized SET program
The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.
Growing evidence links abnormal epigenetic control to the development of hematological malignancies. Accordingly, inhibition of epigenetic regulators is emerging as a promising therapeutic strategy. The acetylation status of lysine residues in histone tails is one of a number of epigenetic post-translational modifications that alter DNA-templated processes, such as transcription, to facilitate malignant transformation. Although histone deacetylases are already being clinically targeted, the role of histone lysine acetyltransferases (KAT) in malignancy is less well characterized. We chose to study this question in the context of acute myeloid leukemia (AML), where, using in vitro and in vivo genetic ablation and knockdown experiments in murine models, we demonstrate a role for the epigenetic regulators CBP and p300 in the induction and maintenance of AML. Furthermore, using selective small molecule inhibitors of their lysine acetyltransferase activity, we validate CBP/p300 as therapeutic targets in vitro across a wide range of human AML subtypes. We proceed to show that growth retardation occurs through the induction of transcriptional changes that induce apoptosis and cell-cycle arrest in leukemia cells and finally demonstrate the efficacy of the KAT inhibitors in decreasing clonogenic growth of primary AML patient samples. Taken together, these data suggest that CBP/p300 are promising therapeutic targets across multiple subtypes in AML.Funding in the Huntly laboratory comes from Cancer Research UK, Leukemia
Lymphoma Research, the Kay Kendal Leukemia Fund, the Leukemia lymphoma
Society of America, the Wellcome Trust, The Medical Research Council and an NIHR
Cambridge Biomedical Research Centre grant. Patient samples were processed in the
Cambridge Blood and Stem Cell Biobank.This is the author accepted manuscript. The final version is available via NPG at http://dx.doi.org/10.1038/onc.2015.9
FQL: An Extensible Feature Query Language and Toolkit on Searching Software Characteristics for HPC Applications
The amount of large-scale scientific computing software is dramatically increasing. In this work, we designed a new query language, named Feature Query Language (FQL), to collect and extract HPC-related software features or metadata from a quick static code analysis. We also designed and implemented an FQL-based toolkit to automatically detect and present software features using an extensible query repository. A number of large-scale, high performance computing (HPC) scientific applications have been studied in the paper with the FQL toolkit to demonstrate the HPC-related feature extraction and information/metadata collection. Different from the existing static software analysis and refactoring tools which focus on software debug, development and code transformation, the FQL toolkit is simpler, significantly lightweight and strives to collect various and diverse software metadata with ease and rapidly
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
OBJECTIVE: Recent studies have reported suboptimal up-titration of heart failure (HF) therapies in patients with heart failure and a reduced ejection fraction (HFrEF). Here, we report on the achieved doses after nurse-led up-titration, reasons for not achieving the target dose, subsequent changes in left ventricular ejection fraction (LVEF), and mortality. METHODS: From 2012 to 2018, 378 HFrEF patients with a recent (< 3 months) diagnosis of HF were referred to a specialised HF-nurse led clinic for protocolised up-titration of guideline-directed medical therapy (GDMT). The achieved doses of GDMT at 9 months were recorded, as well as reasons for not achieving the optimal dose in all patients. Echocardiography was performed at baseline and after up-titration in 278 patients. RESULTS: Of 345 HFrEF patients with a follow-up visit after 9 months, 69% reached ≥ 50% of the recommended dose of renin-angiotensin-system (RAS) inhibitors, 73% reached ≥ 50% of the recommended dose of beta-blockers and 77% reached ≥ 50% of the recommended dose of mineralocorticoid receptor antagonists. The main reasons for not reaching the target dose were hypotension (RAS inhibitors and beta-blockers), bradycardia (beta-blockers) and renal dysfunction (RAS inhibitors). During a median follow-up of 9 months, mean LVEF increased from 27.6% at baseline to 38.8% at follow-up. Each 5% increase in LVEF was associated with an adjusted hazard ratio of 0.84 (0.75–0.94, p = 0.002) for mortality and 0.85 (0.78–0.94, p = 0.001) for the combined endpoint of mortality and/or HF hospitalisation after a mean follow-up of 3.3 years. CONCLUSIONS: This study shows that protocolised up-titration in a nurse-led HF clinic leads to high doses of GDMT and improvement of LVEF in patients with new-onset HFrEF. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s12471-021-01591-6) contains supplementary material, which is available to authorized users
A longitudinal study of muscle strength and function in patients with cancer cachexia
Purpose
Patients with cancer frequently experience an involuntary loss of weight (in particular loss of muscle mass), defined as cachexia, with profound implications for independence and quality of life. The rate at which such patients’ physical performance declines has not been well established. The aim of this study was to determine the change in muscle strength and function over 8 weeks in patients with already established cancer cachexia, to help inform the design and duration of physical activity interventions applicable to this patient group.
Methods
Patients with thoracic and gastrointestinal cancer, with unintentional weight loss of >5% in 6 months or BMI < 20 plus 2% weight loss were included. Physical and functional assessments (baseline, 4 weeks, 8 weeks) included: isometric quadriceps and hamstring strength, handgrip, standing balance, 10m walk time and timed up and go.
Results
Fifty patients (32 male), mean ±SD age 65 ±10 years and BMI 24.9 ±4.3kg/m2 were recruited. Thoracic cancer patients had lower muscle strength and function (p0.05). Baseline variables did not differentiate between completers and non-completers (p>0.05).
Conclusions
More than a third of patients with established cancer cachexia in our study were stable over 8 weeks, suggesting a subgroup who may benefit from targeted interventions of reasonable duration. Better understanding the physical performance parameters which characterize and differentiate these patients has important clinical implications for cancer multidisciplinary team practice
- …